
Aktiviere Job-Benachrichtigungen per E-Mail!
Erstelle in nur wenigen Minuten einen maßgeschneiderten Lebenslauf
Überzeuge Recruiter und verdiene mehr Geld. Mehr erfahren
A leading medical research institution located in Frankfurt is seeking a Postdoctoral Researcher to focus on IVT-mRNA-based reactivation of tumor suppressor pathways in ovarian cancer. The role involves conducting cutting-edge research and collaborating with a multidisciplinary team in a dynamic environment. Ideal candidates will have a Ph.D. and experience with mouse models and bioluminescence imaging.
...you're in the middle of it
The Department of Molecular and Oncological Gynecology at the University Hospital Frankfurt invites applications for a Postdoctoral Researcher position at earliest possible time to join an innovative project investigating IVT-mRNA–based reactivation of tumor suppressor pathways in ovarian cancer. The position is located in a dynamic and collaborative research environment focusing on novel therapeutic strategies to overcome drug resistance in high-grade serous ovarian cancer. The project centers on the development and preclinical validation of next-generation lipid nanoparticle (LNP) carriers for IVT-mRNA delivery, both functionalized and non-functionalized with antibodies. These systems will be evaluated in patient-derived organoids and in vivo, using orthotopic and metastatic ovarian cancer mouse models, including PDX models, with the aim to improve targeted therapy and translational application.
The position is a limited appointment for a duration of two years.
Contact: Priv. Doz. Dr. Mourad Sanhaji, Group Leader. Phone or Email: 069-6301-6894. Application Deadline: 19.12.2025.
We welcome applications from candidates of all genders. Women are currently underrepresented in these positions at Universitätsmedizin Frankfurt. Therefore, applications from women are especially encouraged. Applicants with severe disabilities will be given preferential consideration in cases of equal personal and professional qualifications.